Skip to content
Screener

Claritev Corporation CTEV Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$6.07B+5.6%
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
$43.21M-59.8%
IQVIA logo
IQVIAIQV
$130M+1,525%
Astrana Health logo
Astrana HealthASTH
$14.93M+194%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$63K+150%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$55.74M+10.0%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemJune 30, 2026December 31, 2025
Additional paid-in capital2,410,8312,398,423
Accumulated deficit(2,562,206)(2,429,420)
Accumulated other comprehensive loss(955)(4,172)
Treasury stock - 879,075 and 742,859 shares as of June 30, 2026 and December 31, 2025, respectively(142,236)(138,733)
Total shareholders’ (deficit)/equity attributable to Claritev Corporation(294,564)(173,900)
Non-controlling interests6,7256,725
Total shareholders' deficit(287,839)(167,175)
Total liabilities and shareholders’ deficit$4,763,857$4,888,458

Item 1. Financial Statements

FAQ

What is Claritev Corporation's noncontrolling interests in subsidiaries?
Claritev Corporation (CTEV) reported noncontrolling interests in subsidiaries of $6.73M in Q2 2026.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about Claritev Corporation's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude